126 related articles for article (PubMed ID: 37596912)
21. Coordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling.
Mitani T; Harada N; Nakano Y; Inui H; Yamaji R
J Biol Chem; 2012 Sep; 287(40):33594-606. PubMed ID: 22865883
[TBL] [Abstract][Full Text] [Related]
22. PDGFRbeta and HIF-1alpha inhibition with imatinib and radioimmunotherapy of experimental prostate cancer.
Kimura Y; Inoue K; Abe M; Nearman J; Baranowska-Kortylewicz J
Cancer Biol Ther; 2007 Nov; 6(11):1763-72. PubMed ID: 17986854
[TBL] [Abstract][Full Text] [Related]
23. Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo.
Nardinocchi L; Pantisano V; Puca R; Porru M; Aiello A; Grasselli A; Leonetti C; Safran M; Rechavi G; Givol D; Farsetti A; D'Orazi G
PLoS One; 2010 Dec; 5(12):e15048. PubMed ID: 21179202
[TBL] [Abstract][Full Text] [Related]
24. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells.
Yao H; Wang H; Zhang Z; Jiang BH; Luo J; Shi X
Int J Cancer; 2008 Sep; 123(6):1255-61. PubMed ID: 18561315
[TBL] [Abstract][Full Text] [Related]
25. NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway.
Stewart GD; Nanda J; Brown DJ; Riddick AC; Ross JA; Habib FK
Int J Cancer; 2009 Jan; 124(1):223-32. PubMed ID: 18924134
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer.
Gu J; Li Y; Zeng J; Wang B; Ji K; Tang Y; Sun Q
Sci Rep; 2017 Aug; 7(1):7546. PubMed ID: 28790395
[TBL] [Abstract][Full Text] [Related]
27. Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells.
Jung HJ; Park JW; Lee JS; Lee SR; Jang BC; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2009 Dec; 390(1):71-6. PubMed ID: 19778521
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.
Albadari N; Deng S; Li W
Expert Opin Drug Discov; 2019 Jul; 14(7):667-682. PubMed ID: 31070059
[No Abstract] [Full Text] [Related]
29. BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.
Chen N; Chen X; Huang R; Zeng H; Gong J; Meng W; Lu Y; Zhao F; Wang L; Zhou Q
J Biol Chem; 2009 Apr; 284(15):10004-12. PubMed ID: 19211554
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment.
Mitani T; Yamaji R; Higashimura Y; Harada N; Nakano Y; Inui H
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):58-64. PubMed ID: 21056661
[TBL] [Abstract][Full Text] [Related]
31. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
[TBL] [Abstract][Full Text] [Related]
32. MiR199b suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in prostate cancer cells.
Shang W; Chen X; Nie L; Xu M; Chen N; Zeng H; Zhou Q
Int J Mol Sci; 2013 Apr; 14(4):8422-36. PubMed ID: 23594994
[TBL] [Abstract][Full Text] [Related]
33. Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1.
Huang XZ; Wang J; Huang C; Chen YY; Shi GY; Hu QS; Yi J
Cancer Biol Ther; 2008 Mar; 7(3):468-75. PubMed ID: 18285700
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of a redox-silent analogue of tocotrienol on hypoxia adaptation in prostate cancer cells.
Shiozawa N; Sugahara R; Namiki K; Sato C; Ando A; Sato A; Virgona N; Yano T
Anticancer Drugs; 2017 Mar; 28(3):289-297. PubMed ID: 27926612
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
[TBL] [Abstract][Full Text] [Related]
36. Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
Kazi AA; Gilani RA; Schech AJ; Chumsri S; Sabnis G; Shah P; Goloubeva O; Kronsberg S; Brodie AH
Breast Cancer Res; 2014 Jan; 16(1):R15. PubMed ID: 24472707
[TBL] [Abstract][Full Text] [Related]
37. Castration therapy of prostate cancer results in downregulation of HIF-1α levels.
Al-Ubaidi FL; Schultz N; Egevad L; Granfors T; Helleday T
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1243-8. PubMed ID: 22284032
[TBL] [Abstract][Full Text] [Related]
38. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
39. Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.
Diaz R; Nguewa PA; Redrado M; Manrique I; Calvo A
Prostate; 2015 Aug; 75(11):1137-49. PubMed ID: 25893276
[TBL] [Abstract][Full Text] [Related]
40. SPHK/HIF-1α Signaling Pathway Has a Critical Role in Chrysin-Induced Anticancer Activity in Hypoxia-Induced PC-3 Cells.
Han H; Lee SO; Xu Y; Kim JE; Lee HJ
Cells; 2022 Sep; 11(18):. PubMed ID: 36139362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
